SARS-CoV-2 antibodies, proteins, and ELISA kits

The newly identified coronavirus, SARS-CoV-2 (previously known as 2019-nCoV) shares 79.5% sequence identify with SARS-CoV. The viral genome encodes spike, envelope, membrane, nucleocapsid, and multiple non-structural proteins.

arigo offers quality antibodies, proteins, and ELISA kits to facilitate the research of SARS-CoV-2.

• HMGB1, a biomarker and therapeutic target in COVID-19

• Human anti-SARS-CoV-2 antibody is released

• ACE2, receptor of SARS-CoV-2

SARS-CoV-2 cell entry depends on viral spike protein and ACE2 which mediates conversion of Angiotensin II to Angiotensin 1-7. The receptor-binding domain (RBD) of the spike protein is essential for ACE2 binding. Blocking the interaction of spike protein and ACE2 is a potential therapeutic approach for COVID-19 treatment.

● Spike antibodies 

● Spike proteins

● ACE2 antibodies

● ACE2 proteins

The nucleocapsid protein is a structural protein required for genomic RNA packaging. It is the most abundant protein in coronavirus and often used as a marker in diagnostic assays.

● Nucleocapsid antibodies

● Nucleocapsid proteins

● Nucleocapsid ELISA kit

● E, M and NS proteins ●

● E, M, NS protein antibodies

● E & ORF8 proteins

● More Coronavirus reagents ●

● Antibodies

● Proteins

Download
Flyer of Coronaviruses products
Poster of SARS-CoV & SARS-CoV-2